AU5864901A - 4-aminoquinolines as antiinfective agents - Google Patents
4-aminoquinolines as antiinfective agentsInfo
- Publication number
- AU5864901A AU5864901A AU58649/01A AU5864901A AU5864901A AU 5864901 A AU5864901 A AU 5864901A AU 58649/01 A AU58649/01 A AU 58649/01A AU 5864901 A AU5864901 A AU 5864901A AU 5864901 A AU5864901 A AU 5864901A
- Authority
- AU
- Australia
- Prior art keywords
- aminoquinolines
- antiinfective agents
- antiinfective
- agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/46—Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/58—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
- C07D215/60—N-oxides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0012874 | 2000-05-27 | ||
GBGB0012874.4A GB0012874D0 (en) | 2000-05-27 | 2000-05-27 | 4-Aminoquinolines |
PCT/GB2001/002369 WO2001092232A1 (en) | 2000-05-27 | 2001-05-29 | 4-aminoquinolines as antiinfective agents |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5864901A true AU5864901A (en) | 2001-12-11 |
Family
ID=9892458
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU58649/01A Abandoned AU5864901A (en) | 2000-05-27 | 2001-05-29 | 4-aminoquinolines as antiinfective agents |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU5864901A (en) |
GB (1) | GB0012874D0 (en) |
WO (1) | WO2001092232A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7652039B2 (en) | 2002-05-17 | 2010-01-26 | Sequella, Inc. | Methods of use and compositions for the diagnosis and treatment of infectious disease |
US20040033986A1 (en) * | 2002-05-17 | 2004-02-19 | Protopopova Marina Nikolaevna | Anti tubercular drug: compositions and methods |
CN107427506A (en) | 2014-10-14 | 2017-12-01 | 拉霍拉敏感及免疫学研究所 | Inhibitor of low molecular weight protein tyrosine phosphatase and application thereof |
EP3619210A4 (en) | 2017-05-01 | 2020-12-02 | Sanford Burnham Prebys Medical Discovery Institute | Inhibitors of low molecular weight protein tyrosine phosphatase (lmptp) and uses thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB974348A (en) * | 1961-01-25 | 1964-11-04 | Parke Davis & Co | Basic 7-chloroquinoline-1-oxide derivatives and methods for their production |
US3136769A (en) * | 1961-03-28 | 1964-06-09 | Parke Davis & Co | Quinoline nu-oxides |
US4288595A (en) * | 1980-04-24 | 1981-09-08 | American Home Products Corporation | 7-(Substituted)-7H-pyrrolo[3,2-f]quinazoline-1,3-diamines |
WO1986006718A1 (en) * | 1985-05-17 | 1986-11-20 | The Australian National University | Antimalarial compounds |
CA2133620A1 (en) * | 1993-10-28 | 1995-04-29 | Werner Hofheinz | Aminoquinoline derivatives |
GB9904419D0 (en) * | 1999-02-25 | 1999-04-21 | Univ Liverpool | 4-aminoquinolines |
-
2000
- 2000-05-27 GB GBGB0012874.4A patent/GB0012874D0/en not_active Ceased
-
2001
- 2001-05-29 AU AU58649/01A patent/AU5864901A/en not_active Abandoned
- 2001-05-29 WO PCT/GB2001/002369 patent/WO2001092232A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
GB0012874D0 (en) | 2000-07-19 |
WO2001092232A1 (en) | 2001-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AUPQ713000A0 (en) | Kneepad | |
AU2001262847A1 (en) | Language-understanding | |
AU2001254546A1 (en) | Aminopiperidines | |
AU2000267458A1 (en) | Hypercomputer | |
AU2001288040A1 (en) | Homeostasis-maintaining agents | |
AU2002214284A1 (en) | Anti-helicobacterial agents | |
AU2001239310A1 (en) | Decahydro-isoquinolines | |
AU2001220246A1 (en) | Neckphone | |
AU2001258349A1 (en) | Bisacylguanidine | |
EP1151667A3 (en) | Plant-activating agent | |
AU2001279754A1 (en) | Indoloquinazolinones | |
AU2001285886A1 (en) | 2-guanidino-4-aryl-quinazoline | |
AU2001258924A1 (en) | Microsatellite-aflp | |
AU5789001A (en) | Macrolide antiinfective agents | |
AU2001281921A1 (en) | Bdellosomes | |
AU2001246864A1 (en) | Hypotensors | |
AU2002251688A1 (en) | Machining | |
AU2002214354A1 (en) | Neck-phone | |
AU5864901A (en) | 4-aminoquinolines as antiinfective agents | |
AU2002216249A1 (en) | Antimicrobial agents | |
AUPR099200A0 (en) | New formulation | |
AU2001262711A1 (en) | Cytoprotectors | |
AU2001226668A1 (en) | Crankshaft-starter-generator | |
AU2001284173A1 (en) | Calycins | |
AU2001260192A1 (en) | Glycinamides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |